Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate Cancer

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Virology

• Publication date

  2015-03-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.00257-15PMID 25741004PMCID PMC4442527
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Castration-resistant prostate cancer: latest evidence and therapeutic implications

  2014influential reference
• Viruses for tumor therapy.

  2014cited by this paper
• Re-engineering vesicular stomatitis virus to abrogate neurotoxicity, circumvent humoral immunity, and enhance oncolytic potency.

  2014cited by this paper
• Going viral with cancer immunotherapy

  2014cited by this paper
• High-risk prostate cancer: a disease of genomic instability.

  2014cited by this paper
• Neuroattenuation of Vesicular Stomatitis Virus through Picornaviral Internal Ribosome Entry Sites

  2013cited by this paper
• Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling.

  2013cited by this paper
• Vesicular Stomatitis Virus as an Oncolytic Agent against Pancreatic Ductal Adenocarcinoma

  2013cited by this paper
• Histone Deacetylase Inhibitors Potentiate Vesicular Stomatitis Virus Oncolysis in Prostate Cancer Cells by Modulating NF-κB-Dependent Autophagy

  2013cited by this paper
• Targeting and killing of metastatic cells in the transgenic adenocarcinoma of mouse prostate model with vesicular stomatitis virus.

  2013cited by this paper
• Triptolide-mediated inhibition of interferon signaling enhances vesicular stomatitis virus-based oncolysis.

  2013influential reference
• Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer.

  2012cited by this paper
• Abstract 2833: The protein ps20 increases tumourigenic potential in prostate cancer epithelial cells

  2012cited by this paper
• Vesicular Stomatitis Virus as an Oncolytic Agent against Pancreatic Ductal Adenocarcinoma

  2012cited by this paper
• Regulation of SHP2 by PTEN/AKT/GSK-3β signaling facilitates IFN-γ resistance in hyperproliferating gastric cancer.

  2012cited by this paper
• The protein kinase Akt1 regulates the interferon response through phosphorylation of the transcriptional repressor EMSY

  2012cited by this paper
• Retargeting Vesicular Stomatitis Virus Using Measles Virus Envelope Glycoproteins

  2012cited by this paper
• Suppression of Tak1 promotes prostate tumorigenesis.

  2012cited by this paper
• Vesicular stomatitis virus as a treatment for colorectal cancer

  2011cited by this paper
• Mutations in the Glycoprotein of Vesicular Stomatitis Virus Affect Cytopathogenicity: Potential for Oncolytic Virotherapy

  2011cited by this paper
• Oncolytic Vesicular Stomatitis Virus Induces Apoptosis in U87 Glioblastoma Cells by a Type II Death Receptor Mechanism and Induces Cell Death and Tumor Clearance In Vivo

  2011cited by this paper
• Peripheral, but not central nervous system, type I interferon expression in mice in response to intranasal vesicular stomatitis virus infection

  2011cited by this paper
• Molecular genetics of prostate cancer: new prospects for old challenges.

  2010cited by this paper
• Vesicular stomatitis virus modified with single chain IL-23 exhibits oncolytic activity against tumor cells in vitro and in vivo.

  2010cited by this paper
• Susceptibility of breast cancer cells to an oncolytic matrix (M) protein mutant of vesicular stomatitis virus

  2010cited by this paper
• Oncolysis of prostate cancers induced by vesicular stomatitis virus in PTEN knockout mice.

  2010cited by this paper
• 1,25‐dihydroxyvitamin D3 and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells

  2010cited by this paper
• Abstract 1367: The dual selective VEGFR-FGFR kinases inhibitor E-3810 decreases tumor perfusion and inhibits tumor growth: an analysis using dynamic contrast-enhanced magnetic resonance imaging

  2010cited by this paper
• Glycogen Synthase Kinase-3β Facilitates IFN-γ-Induced STAT1 Activation by Regulating Src Homology-2 Domain-Containing Phosphatase 21

  2009cited by this paper
• Early Steps of the Virus Replication Cycle Are Inhibited in Prostate Cancer Cells Resistant to Oncolytic Vesicular Stomatitis Virus

  2008influential reference
• Immune Response in the Absence of Neurovirulence in Mice Infected with M Protein Mutant Vesicular Stomatitis Virus

  2008cited by this paper
• Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy.

  2008cited by this paper
• Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes.

  2008cited by this paper
• Characterization of Adult Prostatic Progenitor/Stem Cells Exhibiting Self‐Renewal and Multilineage Differentiation

  2008cited by this paper
• Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids.

  2007cited by this paper
• Preferential Translation of Vesicular Stomatitis Virus mRNAs Is Conferred by Transcription from the Viral Genome

  2006cited by this paper
• Recent progress in the battle between oncolytic viruses and tumours

  2005cited by this paper
• Targeting Human Glioblastoma Cells: Comparison of Nine Viruses with Oncolytic Potential

  2005cited by this paper
• Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice

  2005cited by this paper
• Mechanisms of type-I- and type-II-interferon-mediated signalling

  2005cited by this paper
• Culture of mouse prostatic epithelial cells from genetically engineered mice

  2005cited by this paper
• Interaction between the Androgen Receptor and RNase L Mediates a Cross-talk between the Interferon and Androgen Signaling Pathways*

  2005cited by this paper
• Androgen-Independent Prostate Cancer Is a Heterogeneous Group of Diseases

  2004cited by this paper
• Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses.

  2004influential reference
• Vesicular Stomatitis Virus as an Oncolytic Vector

  2004cited by this paper
• The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyltransferase suicide gene.

  2003cited by this paper
• Development of Recombinant Vesicular Stomatitis Viruses That Exploit Defects in Host Defense To Augment Specific Oncolytic Activity

  2003cited by this paper
• Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.

  2003cited by this paper
• Ability of the Matrix Protein of Vesicular Stomatitis Virus To Suppress Beta Interferon Gene Expression Is Genetically Correlated with the Inhibition of Host RNA and Protein Synthesis

  2003cited by this paper
• VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents.

  2003cited by this paper
• Cre/loxP‐mediated inactivation of the murine Pten tumor suppressor gene

  2002cited by this paper
• Delivery of the Cre recombinase by a self-deleting lentiviral vector: Efficient gene targeting in vivo

  2001cited by this paper
• Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation.

  2001cited by this paper
• Matrix Protein and Another Viral Component Contribute to Induction of Apoptosis in Cells Infected with Vesicular Stomatitis Virus

  2001cited by this paper
• Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

  2000cited by this paper
• Vesicular Stomatitis Virus (VSV) Therapy of Tumors

  2000cited by this paper
• The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway.

  1998cited by this paper
• Potency of wild-type and temperature-sensitive vesicular stomatitis virus matrix protein in the inhibition of host-directed gene expression.

  1996cited by this paper
• Evidence for involvement of protein kinase C in the cellular response to interferon alpha.

  1990cited by this paper
• Collagen gel culture system and analysis of estrogen effects on mammary carcinogenesis

  1984cited by this paper
• [Cancer cells].

  1950cited by this paper

• Constitutive NF-kB Activation Is Amplified by VSV in Aggressive PC3 Prostate Cancer Cells That Resist Viral Oncolysis

  2025cites this paper
• NEBL and AKT1 maybe new targets to eliminate the colorectal cancer cells resistance to oncolytic effect of vesicular stomatitis virus M-protein

  2021cites this paper
• Diversity in responses to oncolytic Lassa-vesicular stomatitis virus in patient-derived glioblastoma cells

  2021cites this paper
• MAP3K7 and CHD1 Are Novel Mediators of Resistance to Oncolytic Vesicular Stomatitis Virus in Prostate Cancer Cells

  2020cites this paper
• PTEN Lipid Phosphatase Activity Enhances Dengue Virus Production through Akt/FoxO1/Maf1 Signaling

  2020cites this paper
• Radiation Attenuates Prostate Tumor Antiviral Responses to Vesicular Stomatitis Virus Containing IFNβ, Resulting in Pronounced Antitumor Systemic Immune Responses

  2020cites this paper
• Histone Deacetylase Inhibitors Enhance Cell Killing and Block Interferon-Beta Synthesis Elicited by Infection with an Oncolytic Parainfluenza Virus

  2019cites this paper
• Defects in interferon pathways as potential biomarkers of sensitivity to oncolytic viruses

  2018cites this paper
• Mutations in GAS5 affect the transformation from benign prostate proliferation to aggressive prostate cancer by affecting the transcription efficiency of GAS5

  2018cites this paper
• Oncolytic activity of the rhabdovirus VSV‐GP against prostate cancer

  2018cites this paper
• Parainfluenza Virus Infection Sensitizes Cancer Cells to DNA-Damaging Agents: Implications for Oncolytic Virus Therapy

  2018cites this paper
• THE PRECLINICAL DEVELOPMENT OF ONCOLYTIC VIRAL IMMUNOTHERAPY FOR EPITHELIAL CANCER

  2017cites this paper
• Virus, Oncolytic Virus and Human Prostate Cancer.

  2017cites this paper
• VSV based virotherapy in ovarian cancer: the past, the present and …future?

  2017cites this paper
• Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update.

  2017cites this paper
• Oncogenes: The Passport for Viral Oncolysis Through PKR Inhibition

  2016cites this paper